# Early Feasibility Study of Somatostatin Receptors PET Imaging for the Diagnosis of Infective Endocarditis

> **NCT05183555** · PHASE2 · COMPLETED · sponsor: **Central Hospital, Nancy, France** · enrollment: 14 (actual)

## Conditions studied

- Infective Endocarditis

## Interventions

- **DRUG:** 68Ga-DOTATOC PET/CT

## Key facts

- **NCT ID:** NCT05183555
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-16
- **Primary completion:** 2024-06-18
- **Final completion:** 2024-06-18
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2024-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05183555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05183555, "Early Feasibility Study of Somatostatin Receptors PET Imaging for the Diagnosis of Infective Endocarditis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05183555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*